Active Ingredient History
MSC may refer to: Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Abortion, Habitual (Phase 1/Phase 2)
Aggressive Periodontitis (Phase 1/Phase 2)
Alzheimer Disease (Phase 2)
Bone and Bones (Phase 1/Phase 2)
Bone Diseases (Early Phase 1)
Burns (Phase 1/Phase 2)
Cerebral Hemorrhage (Phase 1)
Chronic Limb-Threatening Ischemia (Phase 2)
Cornea (Phase 1)
Corneal Diseases (Phase 1)
Coronavirus Infections (Phase 1)
COVID-19 (Phase 2/Phase 3)
Crohn Disease (Phase 2/Phase 3)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Diabetic Foot (Phase 2)
Epidermolysis Bullosa Dystrophica (Phase 1/Phase 2)
Fistula (Phase 2/Phase 3)
Fractures, Bone (Phase 1/Phase 2)
Graft vs Host Disease (Phase 2)
Heart Diseases (Phase 2)
Hemorrhagic Stroke (Phase 1)
Hidradenitis Suppurativa (Phase 1/Phase 2)
Intervertebral Disc Degeneration (Phase 2)
Ischemic Stroke (Phase 1/Phase 2)
Leg Length Inequality (Phase 1)
Low Back Pain (Phase 2)
Mesenchymal Stem Cells (Phase 2)
Myocardial Ischemia (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 3)
Osteonecrosis (Phase 1)
Pneumonia, Viral (Phase 1)
Pseudarthrosis (Phase 1/Phase 2)
Pulmonary Emphysema (Phase 2)
Rhinitis, Allergic (Phase 1)
Safety (Phase 1)
Stroke (Phase 1/Phase 2)
Tuberculosis, Spinal (Phase 2)
Xerostomia (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue